Basket cover image
15 handpicked stocks

AI & Robotics Architects

Invest in companies that own the foundational patents powering our AI future. These carefully selected stocks represent firms whose intellectual property forms the blueprint for machine learning and automation, giving them a powerful competitive advantage for years to come.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+5

Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at जून 17

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

NVDA

NVIDIA Corporation

NVDA

Current price

$175.64

A leader in GPUs and AI-specific hardware, its patents are fundamental to the computing power required for machine learning.

GOOG

Alphabet Inc. - Class C Shares

GOOG

Current price

$202.49

Possesses a vast patent library in AI, particularly in search algorithms, neural networks (TensorFlow), and autonomous systems through Waymo.

MSFT

Microsoft Corporation

MSFT

Current price

$509.77

Holds a significant number of patents in software and AI, amplified by its strategic investments and integration with OpenAI's technologies.

About This Group of Stocks

1

Our Expert Thinking

This portfolio targets companies with the most valuable intellectual property in AI and robotics. These firms own the patents behind neural networks, computer vision, and automated systems - creating competitive moats through both direct application and licensing of their foundational technologies.

2

What You Need to Know

These stocks represent companies creating the essential infrastructure of the AI revolution. With enterprise AI adoption accelerating and demand for automated supply chains growing, these patent-rich companies are positioned at the intersection of innovation and commercial application.

3

Why These Stocks

We've identified companies with high volumes of granted patents in critical technologies like machine learning, autonomous systems, and industrial automation. These aren't just any tech companies - they're the ones creating the technological building blocks that countless other innovations depend on.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+283.01%

Group Performance Snapshot

283.01%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 283.01% over the next year.

10 of 14

Stocks Rated Buy by Analysts

10 of 14 assets in this group are rated Buy by professional analysts.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

🧠

The Building Blocks of AI

These companies don't just participate in AI - they own the patents that make it possible. As AI adoption continues to accelerate, these foundational technologies become increasingly valuable.

🔐

Protected by Patents

Intellectual property creates powerful competitive moats. These companies have secured their innovations with extensive patent portfolios, potentially generating revenue through both products and licensing for years to come.

🚀

Riding Multiple Growth Waves

From autonomous vehicles to factory automation to cloud AI services - these companies are positioned at the intersection of multiple transformative technological trends all at once.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

The New Cost of Compliance: Investing in HR Tech

The New Cost of Compliance: Investing in HR Tech

Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.

View stocks
GLP-1s Target Liver Disease

GLP-1s Target Liver Disease

The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.

View stocks
Pharma's Digital Prescription

Pharma's Digital Prescription

Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.

View stocks
View All

Frequently Asked Questions

Everything you need to know about the product and billing.